Authors:
Takeda, K
Hayakawa, Y
Smyth, M
Kayagaki, N
Yamaguchi, N
Kakuta, S
Iwakura, Y
Yagita, H
Okumura, K
Citation: K. Takeda et al., Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells, NAT MED, 7(1), 2001, pp. 94-100
Authors:
Oshima, K
Yanase, N
Ibukiyama, C
Yamashina, A
Kayagaki, N
Yagita, H
Mizuguchi, J
Citation: K. Oshima et al., Involvement of trail/trail-R interaction in IFN-alpha-induced apoptosis ofdaudi B lymphoma cells, CYTOKINE, 14(4), 2001, pp. 193-201
Authors:
Nisihara, T
Ushio, Y
Higuchi, H
Kayagaki, N
Yamaguchi, N
Soejima, K
Matsuo, S
Maeda, H
Eda, Y
Okumura, K
Yagita, H
Citation: T. Nisihara et al., Humanization and epitope mapping of neutralizing anti-human fas ligand monoclonal antibodies: Structural insights into Fas/Fas ligand interaction, J IMMUNOL, 167(6), 2001, pp. 3266-3275
Authors:
Miura, Y
Misawa, N
Maeda, N
Inagaki, Y
Tanaka, Y
Ito, M
Kayagaki, N
Yamamoto, N
Yagita, H
Mizusawa, H
Koyanagi, Y
Citation: Y. Miura et al., Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4(+) T cells in HIV-1-infected hu-PBL-NOD-SCID mice, J EXP MED, 193(5), 2001, pp. 651-659
Authors:
Sato, K
Hida, S
Takayanagi, H
Yokochi, T
Kayagaki, N
Takeda, K
Yagita, H
Okumura, K
Tanaka, N
Taniguchi, T
Ogasawara, K
Citation: K. Sato et al., Antiviral response by natural killer cells through TRAIL gene induction byIFN-alpha/beta, EUR J IMMUN, 31(11), 2001, pp. 3138-3146
Authors:
Nieda, M
Nicol, A
Koezuka, Y
Kikuchi, A
Lapteva, N
Tanaka, Y
Tokunaga, K
Suzuki, K
Kayagaki, N
Yagita, H
Hirai, H
Juji, T
Citation: M. Nieda et al., TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells, BLOOD, 97(7), 2001, pp. 2067-2074
Authors:
Shinohara, H
Kayagaki, N
Yagita, H
Oyaizu, N
Ohba, M
Kuroki, T
Ikawa, Y
Citation: H. Shinohara et al., A protective role of PKC epsilon against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells, BIOC BIOP R, 284(5), 2001, pp. 1162-1167
Authors:
Seino, K
Setoguchi, Y
Ogino, T
Kayagaki, N
Akiba, H
Nakano, H
Taniguchi, H
Takada, Y
Yuzawa, K
Todoroki, T
Fukuchi, Y
Yagita, H
Okumura, K
Fukao, K
Citation: K. Seino et al., Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappa Bactivation, ANN SURG, 234(5), 2001, pp. 681-688
Authors:
Saitoh, A
Kawanabe, T
He, WD
Kayagaki, N
Kawamura, T
Yagita, H
Okumura, K
Shimada, S
Citation: A. Saitoh et al., Selective upregulation of fibroblast fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: The skin as a retinoide-inducible immune privilege site, J INVES DER, 115(2), 2000, pp. 154-161
Authors:
Yamanaka, K
Tanaka, M
Tsutsui, H
Kupper, TS
Asahi, K
Okamura, H
Nakanishi, K
Suzuki, M
Kayagaki, N
Black, RA
Miller, DK
Nakashima, K
Shimizu, M
Mizutani, H
Citation: K. Yamanaka et al., Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18, J IMMUNOL, 165(2), 2000, pp. 997-1003
Authors:
Tsutsui, H
Kayagaki, N
Kuida, K
Nakano, H
Hayashi, N
Takeda, K
Matsui, K
Kashiwamura, S
Hada, T
Akira, S
Yagita, H
Okamura, H
Nakanishi, K
Citation: H. Tsutsui et al., Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice, IMMUNITY, 11(3), 1999, pp. 359-367
Authors:
Nagao, M
Nakajima, Y
Hisanaga, M
Kayagaki, N
Kanehiro, H
Aomatsu, Y
Ko, S
Yagita, H
Yamada, T
Okumura, K
Nakano, H
Citation: M. Nagao et al., The alteration of Fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo?, HEPATOLOGY, 30(2), 1999, pp. 413-421
Authors:
Hattori, K
Hirano, T
Ushiyama, C
Miyajima, H
Yamakawa, N
Ikeda, S
Yoshino, K
Tateno, M
Oshimi, K
Kayagaki, N
Yagita, H
Okumura, K
Citation: K. Hattori et al., A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation, BONE MAR TR, 23(12), 1999, pp. 1283-1289
Authors:
Kayagaki, N
Yamaguchi, N
Nakayama, M
Takeda, K
Akiba, H
Tsutsui, H
Okamura, H
Nakanishi, K
Okumura, K
Yagita, H
Citation: N. Kayagaki et al., Expression and function of TNF-related apoptosis-inducing ligand on murineactivated NK cells, J IMMUNOL, 163(4), 1999, pp. 1906-1913
Authors:
Kayagaki, N
Yamaguchi, N
Nakayama, M
Kawasaki, A
Akiba, H
Okumura, K
Yagita, H
Citation: N. Kayagaki et al., Involvement of TNF-related apoptosis-inducing ligand in human CD4(+) T cell-mediated cytotoxicity, J IMMUNOL, 162(5), 1999, pp. 2639-2647
Authors:
Hyodo, Y
Matsui, K
Hayashi, N
Tsutsui, H
Kashiwamura, S
Yamauchi, H
Hiroishi, K
Takeda, K
Tagawa, Y
Iwakura, Y
Kayagaki, N
Kurimoto, M
Okamura, H
Hada, T
Yagita, H
Akira, S
Nakanishi, K
Higashino, K
Citation: Y. Hyodo et al., IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor, J IMMUNOL, 162(3), 1999, pp. 1662-1668
Authors:
Kayagaki, N
Yamaguchi, N
Nakayama, M
Eto, H
Okumura, K
Yagita, H
Citation: N. Kayagaki et al., Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism forthe antitumor effects of type IIFNs, J EXP MED, 189(9), 1999, pp. 1451-1460
Authors:
Hiromatsu, Y
Hoshino, T
Yagita, H
Koga, M
Sakisaka, S
Honda, J
Yang, D
Kayagaki, N
Okumura, K
Nonaka, K
Citation: Y. Hiromatsu et al., Functional Fas ligand expression in thyrocytes from patients with Graves' disease, J CLIN END, 84(8), 1999, pp. 2896-2902
Authors:
Kim, YH
Kim, SS
Kim, KA
Yagita, H
Kayagaki, N
Kim, KW
Lee, MS
Citation: Yh. Kim et al., Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NODmice: no role of Fas-Fas ligand interaction in autoimmune diabetes, EUR J IMMUN, 29(2), 1999, pp. 455-465